CI
Cambridge Innovation Capital
Venture CapitalActiveCIC backs life sciences and technology companies in EuropeвАЩs leading ecosystem, Cambridge. A preferred investor for the university.
58
Investments
7
Exits
$1.0B
AUM
12.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Cambridge Innovation Capital.
Investment Thesis & Strategy
Cambridge Innovation Capital invests in life sciences and technology companies, with a preference for those in the Cambridge ecosystem, and often invests in companies affiliated with the university, across various stages.
Investment Activity
Deals per year over the last 7 years
2
20160
20172
20181
20191
20205
20211
2022Portfolio Companies
Selected investments from their portfolio of 58 companies
B
Baseimmune
Biotech · Series A, 2022
P
Pragmatic Semiconductor
Other · Series B, 2021
P
Peptone
Biotech · Series A, 2021
C
Cambridge GaN Devices
Cleantech · Series A, 2021
B
Bit.bio
Biotech · Series B, 2021
o
o2h therapeutics
Biotech · Series A, 2021
Q
Qkine
Biotech · Series A, 2020
R
Riverlane
AI/ML · Series A, 2019
P
Paragraf
Other · Series A, 2018
N
Nu Quantum
Other · Series A, 2018
C
Congenica
Healthcare · Series B, 2016
A
Aqdot
Other · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
CMR SurgicalAcquisition2024—
GraphcoreAcquisition2024—
FeaturespaceAcquisition2023—
AqdotAcquisition2023—
CongenicaAcquisition2023—
RiverlaneAcquisition2023—
NuformixIPO2018—
Frequently Asked Questions
Cambridge Innovation Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Amadeus Capital Partners
Cambridge, United Kingdom · 224 deals
SyndicateRoom
Cambridge, United Kingdom · 89 deals
IQ Capital
Cambridge, United Kingdom · 81 deals
Martlet Capital
Cambridge, United Kingdom · 36 deals
GEIF Ventures
Cambridge, United Kingdom · 19 deals
Acacia Capital Partners
Cambridge, United Kingdom · 9 deals